Research Progress of Glycyrrhizic Acid on Antiviral Activity

(E-pub Abstract Ahead of Print)

Author(s): Zhi-Gang Sun*, Ting-Ting Zhao, Na Lu, Yong-An Yang, Hai-Liang Zhu*.

Journal Name: Mini-Reviews in Medicinal Chemistry

Become EABM
Become Reviewer


Glycyrrhizic acid (GA), a triterpene isolated from the roots and rhizomes of licorice, named Glycyrrhiza glabra, is the principal bioactive ingredient of anti-viral, anti-inflammatory and hepatoprotective effects. GA has been used in the clinical treatment of hepatitis, bronchitis, gastric ulcer, AIDS (acquired immunodeficiency syndrome), certain cancers and skin diseases. It has a direct effect on anti-HBV (hepatitis B virus) via affecting the HBsAg (hepatitis B surface antigen) to extracellular secretion, improving liver dysfunction in patients with chronic hepatitis B, and ultimately improving the immune status of HBV. GA can significantly inhibit the proliferation of HIV, showing an immune activation. The clinical application of GA on the prevention and treatments of various diseases may derive from its numerous pharmacological properties. This review provides the summary of the antiviral effects of GA on research progress and mechanism in recent years.

Keywords: glycyrrhizic acid, antiviral effects, hepatitis virus, HIV, influenza virus, herpes virus

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Abstract Ahead of Print)
DOI: 10.2174/1389557519666190119111125
Price: $95